Soltis Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
Soltis Investment Advisors's LLY Position: Q2 2026 in Review
Soltis Investment Advisors increased its Eli Lilly (LLY) stake by 18% in Q2 2026, buying an estimated $910K and bringing the position to 5,809 shares worth $6.97M. The position accounts for 0.39% of the portfolio, ranked #66.
Soltis Investment Advisors first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Soltis Investment Advisors held 5,809 shares of Eli Lilly worth $6.97M as of Q2 2026.
- Soltis Investment Advisors bought 891 Eli Lilly shares in Q2 2026, an estimated $910K.
- Eli Lilly made up 0.39% of Soltis Investment Advisors's portfolio in Q2 2026, its #66 holding.
- Soltis Investment Advisors first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
- 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Soltis Investment Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.